网络高剂量化学治疗 网络释义 1. 高剂量化学治疗 有学者报告,以高剂量化学治疗(high-dose melphalan)合并自体骨髓移植来治疗多发性骨髓瘤,可以得到较高的缓解率。甚… tw.myblog.yahoo.com|基于15个网页
melphalan的高药量 翻译结果5复制译文编辑译文朗读译文返回顶部 高药量melphalan 相关内容 aOn the blow-up problem of compressible Navier–Stokes equations, 在爆炸问题的可压缩Navier升火等式,[translate] aTHIS DRAWING SHOWS ONLY FUNCTIONAL DIMENSIONS ALL OTHER DIMENSIONS HAVE TO BE TAKEN FROM 3D MODEL WHICH...
释义 [医][=high-dose melphalan]高剂量苯丙氨酸氮芥; 英英释义 HDM HDM may stand for: 以上来源于:Wikipedia 学习怎么用 权威例句 HDM—a model for the design of hypertext applications HDM: a model-based approach to hypertext application design ...
High-dose melphalanMinimal residual diseaseMultiple myelomaState of the art treatment for myeloma involves using 3-drug combinations incorporating immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs). Clinical trials for 4-drug combinations incorporating monoclonal antibodies added to IMiD and PI ...
Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation Fludarabine makes up the cornerstone of reduced-intensity conditioning (RIC) regimens for allogeneic stem cell transplant (alloHCT). However, during the na... S On,W Domingo,E Cheung,.....
June 13, 2011 (London, United Kingdom) — Contrary to expectation, progression-free survival in patients with multiple myeloma is longer in patients who receive high-dose melphalan (Alkeran, GlaxoSmithKline) and undergo autologous stem cell transplantation (ASCT) than in those treated with the ...
These results–-in accord with the long-term outcome in other series–-suggest that for neuroblastoma high-dose melphalan cannot be relied on to ablate residual disease or to salvage patients with refractory tumors. In addition, the pattern of relapse in several patients could be explained by...
Nishihori T, Hassoun Y, Zhang L, Shain K, Alsina M, Kharfan- Dabaja MA (2014) High-dose melphalan produces favorable re- sponse in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation. Bone Marrow Transplant 49(1):148-149...
Long-term results are presented of 28 patients who were diagnosed with neuroblastoma at more than 12 months of age and who received melphalan 180 mg/m2 (n = 6) or 240 mg/m2 (n = 22) to consolidate remissions of Stage IV disease or to control refractory disease. Twenty-four patients als...
The application of high-dose melphalan and autologous stem cell transplant (SCT) to systemic AL amyloidosis (AL) has evolved over the past two decades and remains an important component of therapy for patients with AL. The era of novel agents created the opportunity to provide well -tolerated ...